The success of copyright’s blockbuster initially fueled a period of growth for major pharmaceutical companies, but recent shifts present a complicated outlook for shareholders. Generic alternatives are eating into https://bushraanex222963.blog5.net/92892675/sildenafil-and-the-pharmaceutical-industry-a-volatile-bet